ISSCR 2027: A Milestone Stem Cell Meeting Comes to San Francisco

What This Article Covers

The International Society for Stem Cell Research (ISSCR) has confirmed its 2027 Annual Meeting for June 15-18, 2027, at the Moscone West Convention Center in San Francisco. The gathering, billed by ISSCR as "The Global Stem Cell Event," arrives as the society marks roughly 25 years since its founding in 2002, and it is shaping up as one of the field's most closely watched events: a dense four days of peer-reviewed science spanning developmental biology, regenerative medicine, bioengineering, and the AI tools increasingly used to accelerate discovery.

What ISSCR 2027 Is

ISSCR is the leading international membership organization for stem cell scientists, and its annual meeting is widely regarded as the field's premier scientific conference. For 2027, the society has chosen San Francisco — a hub for biotech and academic stem cell research — as the host city, with sessions running at the Moscone West Convention Center from June 15 through June 18. ISSCR has framed the meeting as a showcase for "breakthroughs in development and regeneration to advances in AI, bioengineering and cell therapies," signaling a program that extends well beyond basic biology into the technologies now reshaping how therapies move from bench to clinic.

Who Attends and Why It Matters

The meeting draws a cross-section of the field rarely assembled in one place: academic researchers, clinician-scientists, biotechnology and pharmaceutical representatives, regulators, and a substantial contingent of trainees and early-career scientists. ISSCR has specifically highlighted plans to prioritize opportunities for younger researchers through speaking slots, mentoring programs, and travel awards — a structural choice that matters for a field that depends on a steady pipeline of new scientific talent to keep translating laboratory findings into viable treatments.

Themes and Sessions to Watch

Based on ISSCR's own previews, several threads are likely to run through the 2027 program: - Stem cell-based model systems (including organoids and other engineered tissue models) used to study disease and screen potential therapies - AI-enabled research methods, from computational biology to automation in manufacturing and imaging - Advances in cell therapy development and the engineering challenges of scaling production - Cross-disciplinary sessions connecting basic developmental and regenerative biology to clinical translation

An accompanying exhibition is expected to feature companies and tools across these same categories, giving attendees a practical look at the manufacturing and analytical infrastructure behind the science presented on stage.

Why This Meeting Matters for Patients and the Field

Conferences like ISSCR's annual meeting are where the stem cell field's unpublished and newly published findings first circulate, where methodological standards get debated, and where the society's own research and clinical guidelines — long a reference point for distinguishing rigorous, evidence-based regenerative medicine from unproven offerings — are discussed and refined. For patients and caregivers trying to make sense of a fast-moving and sometimes confusingly marketed field, meetings of this scale are part of the infrastructure that keeps credible science visible and documented, even if the clinical payoff from any single presentation can take years to materialize.

Bottom Line

ISSCR 2027 is a real, confirmed event — June 15-18, 2027, at Moscone West in San Francisco — and one of the most significant dates on the stem cell research calendar for the year. Readers tracking the field's genuine progress, as opposed to premature marketing claims, should watch for ISSCR's session announcements and post-meeting summaries as the date approaches.